摘要: |
目的:观察激活的一磷酸腺苷活化蛋白激酶(AMPK)对软脂酸(PA)诱导的人脐静脉血管内皮细胞(HUVEC)损伤的保护作用,探讨其可能的作用机制.方法:按HUVEC培养液中成分不同,实验分为8组,分别为:空白对照组(常规培养)、PA培养组、5-氨基咪唑-4-甲酰胺核苷酸(AICAR)培养组、PA+AICAR培养组、二甲双胍(Met)培养组、PA+Met培养组、吡格列酮(PGZ)培养组和PA+PGZ培养组.HUVEC在各组培养液中分别培养24、48和72 h,MTT法测定不同时间点各组细胞的存活率,Western印迹法测定培养24 h时各组细胞的磷酸化AMPK蛋白表达水平.结果:与对照组相比,PA组细胞24、48和72 h的存活率明显降低,分别为58.95﹪、36.68﹪和15.09﹪(P<0.05);培养72 h,AICAR+PA组、Met+PA组和PGZ+PA组细胞的存活率均显著高于PA组(P<0.05);单独应用AICAR、Met和PGZ培养对细胞的存活率影响不大,与对照组比较无显著差异.与对照组和PA组相比,培养24 h时,AICAR、Met和PGZ刺激HUVEC的磷酸化AMPK表达增加(P<0.05).结论:AICAR、Met和PGZ可能通过激活AMPK,显著减轻PA诱导的HUVEC的损伤. |
关键词: AMP-活化蛋白激酶、5-氨基-4-甲酰胺核苷酸、二甲双胍、吡格列酮 |
DOI:10.3724/SP.J.1008.2006.00957 |
投稿时间:2006-01-09修订日期:2006-07-15 |
基金项目: |
|
Protective effect of activated AMP-activated protein kinase on palmatic acid-induced damage of human umbilical vein endothelial cells |
CHENG Ying,MU Yi-ming,WANG Bao-an,PAN Chang-yu,LU Ju-ming |
(中国人民解放军成都军区总医院内分泌科,成都,610032;中国人民解放军总医院内分泌科,北京,100853) |
Abstract: |
Objective:To investigate the protective effect of activated AMP-activated protein kinase (AMPK) on the human umbilical vein endothelial cell(HUVEC) damage induced by palmatlc acid (PA) and the related mechanism. Methods: HUVEC were divided into 8 groups according to the culture media (cultured for 24 to 72 h): blank control (conventional culture), 300 μmol/L PA, 1 mmol/L aminoimidazole-4-carboxamide-l-beta-ribofuranoside (AICAR), PA+ AICAR, 2 mmol/L metformin, PAq-metformin, 10 btmol/L pioglitazone, and PAq-pioglitazone groups. Survival rates of HUVEC were determined by MTT at 24, 48 and 72 h after culture. Western blot were performed to detect the expression of phospha-AMPK at 24 h after culture. Results: Compared with blank control group, cell survival rates in PA group were decreased by 58.95M, 36.68% and 15.09M at 24, 48 and 72 h(P〈0.05), respectively. Seventy-two hours after culture, HUVEC survival rates of AICAR-t-PA group, Metnt-pA group and PGZ+PA group were obviously higher than that of PA group (P〈0.05) ; AICAR, metformin or pioglita- zone alone had no obvious influence on HUVEC survival rate. Twenty-four hours after culture, Phospha-AMPK expression was increased in AICAR, metforrnin and pioglitazone groups compared with that of control group (P〈0.05). Conclusion: AICAR, metformin and pioglitazone can decrease the damage of HUVEC induced by PA, possibly through activating AMPK |
Key words: AMP-activated protein kinase 5-amino-4-imidazolecarboxamide-riboside metformin pioglitazone |